Barclays Starts Intellia Therapeutics (NTLA) at Underweight

October 6, 2026 6:11 AM

Barclays analyst Gena Wang initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found